Tweet
dBTechno
<img alt="" height="1" width="1" />
Intermune Soars On FDA Panel, Buyout Speculation
Wall Street Journal
NEW YORK (Dow Jones)--InterMune Inc. (ITMN) shares surged Wednesday to eight-year highs after a panel recommended that the Food and Drug Administration approve its lung-disease treatment. ...
Biotech Gainer: IntermuneTheStreet.com
InterMune shares rise after FDA panel drug votesBusinessWeek
Odds Are High For Approval of InterMune's (ITMN) PirfenidoneBenzinga
MarketNewsVideo.com -The Associated Press -TopNews United States
all 337 news articles »
More...